Insider Transactions in Q2 2021 at Allakos Inc. (ALLK)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.63%
|
$0
$0.69 P/Share
|
|
Jun 15
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.89%
|
$1,820,000
$91.03 P/Share
|
|
Jun 14
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.63%
|
$0
$0.69 P/Share
|
|
Jun 14
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.89%
|
$1,820,000
$91.62 P/Share
|
|
Jun 07
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
2,487
-1.65%
|
$228,804
$92.03 P/Share
|
|
Jun 04
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
642
-0.42%
|
$57,780
$90.26 P/Share
|
|
Jun 04
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,435
-2.41%
|
$216,715
$89.6 P/Share
|
|
Jun 04
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,482
-1.68%
|
$487,898
$89.64 P/Share
|
|
Jun 04
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,113
-3.62%
|
$1,612,057
$89.63 P/Share
|
|
Jun 04
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,516
+5.44%
|
$0
$0.69 P/Share
|
|
Jun 03
2021
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,777
-1.16%
|
$163,484
$92.2 P/Share
|
|
Jun 03
2021
|
Mark Asbury CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-1.16%
|
$67,528
$92.2 P/Share
|
|
Jun 03
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.82%
|
$76,728
$92.2 P/Share
|
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,484
-1.66%
|
$504,528
$92.09 P/Share
|
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,335,564
$92.14 P/Share
|
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,003
-1.63%
|
$368,276
$92.2 P/Share
|
|
Jun 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,484
-1.63%
|
$515,496
$94.56 P/Share
|
|
Jun 02
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
|
Jun 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,364,598
$94.55 P/Share
|
|
May 19
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,516
+5.29%
|
$0
$0.69 P/Share
|
|
May 19
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,516
-5.59%
|
$1,422,568
$98.94 P/Share
|
|
May 18
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
|
May 18
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,480,734
$102.32 P/Share
|
|
May 17
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
|
May 17
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,437,183
$99.68 P/Share
|
|
May 12
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
May 12
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$1,980,000
$99.23 P/Share
|
|
May 11
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
May 11
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$1,940,000
$97.79 P/Share
|
|
May 10
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
May 10
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$1,920,000
$96.02 P/Share
|
|
Apr 19
2021
|
Harlan Baird Radford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,100
+50.0%
|
-
|
|
Apr 14
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Apr 14
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,140,000
$107.77 P/Share
|
|
Apr 13
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Apr 13
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,060,000
$103.08 P/Share
|
|
Apr 12
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Apr 12
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,080,000
$104.4 P/Share
|
|
Apr 06
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.21%
|
$10,000
$1.16 P/Share
|
|
Apr 06
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.94%
|
$1,110,000
$111.68 P/Share
|
|
Apr 05
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.1%
|
$20,000
$1.16 P/Share
|
|
Apr 05
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.42%
|
$2,260,000
$113.06 P/Share
|
|
Apr 01
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.1%
|
$20,000
$1.16 P/Share
|
|
Apr 01
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.42%
|
$2,280,000
$114.4 P/Share
|